Company Overview and News

 
Barclays’s Bhavin Shukla quits, to join JP Morgan

3h livemint
Mumbai:Bhavin Shukla has resigned as director at Barclays India’s investment banking unit and will join JPMorgan’s investment banking unit, said two people aware of the development.

 
Beyond the dollar everything’s ‘just noise’ for emerging markets

2018-05-21 bworldonline
As if emerging-market investors didn’t have enough to worry about — with political flare-ups and central-bank surprises galore — the dollar’s strength is poised to pile further pressure on currencies from the real to the rand.

 
Women call for institutionalized policies to boost gender equality in the workplace

2018-05-20 bworldonline
WOMEN IN various fields want policies institutionalized to strengthen gender equality in the workplace, including the Philippines which is already considered a leader in the Asia Pacific region in terms of practicing and promoting opportunities.

1
21Vianet Group's (VNET) CEO Alvin Wang on Q1 2018 Results - Earnings Call Transcript

2018-05-18 seekingalpha
Good morning and good evening, ladies and gentleman. Thank you and welcome to 21Vianet Group's First Quarter 2018 Earnings Conference Call. At this time, all participants are in listen-only mode. We will be hosting a question-and-answer session after management’s prepared remarks.

 
Novartis announces changes to the Executive Committee | Novartis

2018-05-16 novartis
Basel, May 16, 2018 - Novartis announced today that Felix R. Ehrat, Group General Counsel of Novartis, has decided to retire from the company. Shannon Thyme Klinger, currently Chief Ethics, Risk and Compliance Officer, will be appointed Group General Counsel, effective June 1, 2018.

1
EyePoint Pharmaceuticals Announces Appointment of Leonard Blum as Executive Vice President and General Manager, U.S.

2018-05-16 globenewswire
WATERTOWN, Mass., May 16, 2018 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ:EYPT), a specialty biopharmaceutical company committed to developing and commercializing innovative ophthalmic products, today announced the appointment of Leonard M. Blum as Executive Vice President and General Manager, U.S., effective May 14, 2018. In this role, he will be responsible for the launch of DEXYCU™ (dexamethasone intraocular suspension) 9%, the Company’s U.

 
Novartis announces changes to the Executive Committee

2018-05-16 globenewswire
Basel, May 16, 2018 - Novartis announced today that Felix R. Ehrat, Group General Counsel of Novartis, has decided to retire from the company. Shannon Thyme Klinger, currently Chief Ethics, Risk and Compliance Officer, will be appointed Group General Counsel, effective June 1, 2018.

 
Comment: Argentina crisis 'may be tip of the iceberg'

2018-05-16 nzherald.co.nz
The dramatic events in Argentina may be the "tip of the iceberg" of a broader systemic crisis across Asia, Latin America and Africa, the top emerging market watchdog has warned.

 
Emerging Markets Face Their Moment of Truth - Bloomberg

2018-05-15 bloomberg
Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

1
Inside The Slump in Argentina ETFs

2018-05-15 zacks
Argentina is facing an economic crisis and the central bank has hiked interest rates three times in a span of eight days. On May 4, the interest rate was hiked to 40% from 33.25%, a day after it was raised from 30.25%, which shows an abnormal increase on any economic parameter. The situation has arrived as peso has reached a record low of 25 against the dollar (9% decrease). To make up for this downfall in the first week of May the central bank of Argentina has spent $3 billion on stabilizing its currency (Read: ETFs in Focus on Growth Forecasts for Latin America).

 
21Vianet Group, Inc. Announces Addition to the Board of Directors

2018-05-15 globenewswire
BEIJING, May 15, 2018 (GLOBE NEWSWIRE) -- 21Vianet Group, Inc. (Nasdaq:VNET) ("21Vianet" or the "Company"), a leading carrier-neutral Internet data center services provider in China, today announced that its Board of Directors (the “Board”) has appointed Dr. Yao Li as an independent director and a member of the Company’s Compensation Committee, effective immediately. Dr. Yao Li will also act as the Chairman of the Company’s Strategic Advisory Board, which the Board has resolved to establish in order to utilize its members’ experience in the internet infrastructure industry to provide advice on the Company’s business strategies.

 
Lopez-led EDC urges gov’t to help develop PHL geothermal industry

2018-05-14 bworldonline
THE GOVERNMENT can support the growth of the country’s geothermal industry by helping with the upfront risk that goes with the development of the indigenous energy resource, the president of Energy Development Corp. (EDC) said.

 
Debt alert as governments, firms and families face unprecedented burdens 

2018-05-14 telegraph.co.uk
The true scale of global debts has been revealed in a study of borrowing around the world, showing a total burden of $243 trillion (£179 trillion).

 
OCI's (OCINF) CEO Nassef Sawiris on Q1 2018 Results - Earnings Call Transcript

2018-05-13 seekingalpha
Ladies and gentlemen, thank you all for standing by. And welcome to today’s OCI N.V. First Quarter 2018 Results Conference Call. At this time, all participants are in a listen-only mode. There will be a presentation followed by a question-and-answer session. [Operator Instructions]

 
Weekly Commentary: Disequilibrium

2018-05-13 seekingalpha
Much to the consternation of our allies, President Trump withdraws from the Iran nuclear deal. WTI crude adds another 1.5% (up 17% y-t-d) this week to the high since November 2014. Iran and Israel moved closer to direct military confrontation. With even 40% rates unable to staunch the bleeding, a stunned Argentine government warily negotiates an IMF bailout. Italy's far right and far left parties - both populist, anti-establishment, anti-euro and anti-immigration - begin negotiations to form a coalition government.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...